Trial intelligence / Profile preview

Photodynamic therapy as an adjunct to non-surgical treatment of aggressive periodontitis

RBR-4gq6khrPhase 4Not yet recruiting

Sponsor
Universidade Federal do Rio Grande do Norte
Start
Dec 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of amoxicillin and metronidazole in Aggressive Periodontitis (AP), sponsored by Universidade Federal do Rio Grande do Norte. Planned start Dec 2020; status: not yet recruiting.

02

Drugs

amoxicillinmetronidazole
03

Conditions

Aggressive Periodontitis (AP)

Beyond the preview

Go deeper on RBR-4gq6khr.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-4gq6khr.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call